Medical grade liquid nitrogen market seen reaching $3.39 billion by 2030

The medical grade liquid nitrogen market is projected to grow from $2.48 billion in 2025 to $3.39 billion by 2030, driven by rising demand for cryopreservation, cryosurgery and cell and gene therapy storage. North America leads the market now, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Medical grade liquid nitrogen underpins cryotherapy, cryopreservation and cryosurgical procedures used in healthcare, fertility treatment and research. - Growth in cell and gene therapy, regenerative medicine and biobanking is expanding demand for ultra-high-purity cryogenic supply. - The market's projected 6.4% CAGR through 2030 signals sustained demand for medical-grade cold chain and storage capacity.

What happened: - The Business Research Company projected the medical grade liquid nitrogen market will grow from $2.48 billion in 2025 to $2.64 billion in 2026. - The market is forecast to reach $3.39 billion by 2030. - The company said the forecast implies a 6.4% CAGR over the period. - The report was published Aug. 17, 2026. - The company offered a free sample report and the full market report.

The details: - Historical growth was driven by medical research, dermatology cryotherapy, biobanking, pharmaceutical manufacturing and demand from fertility clinics. - Forecast growth is tied to regenerative medicine, cell and gene therapy storage, ultra-high-purity liquid nitrogen demand, cryogenic logistics investment and healthcare infrastructure development. - Emerging trends include broader use of cryopreservation, higher demand for medical gases, more cold chain and cryogenic storage facilities, greater use of cryosurgical treatments and tighter compliance and traceability requirements. - Medical-grade liquid nitrogen is a highly purified cryogenic liquid nitrogen produced under strict industry standards. - Medical uses include cryotherapy for dermatological conditions, cryopreservation of blood, reproductive cells and stem cells, and cooling in surgical and research settings. - The supply chain is subject to strict traceability and regulatory requirements. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region in the coming years. - The report also covered South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Cryopreservation and cryosurgery are becoming more central to treatment and storage workflows, which increases reliance on consistent liquid nitrogen supply. - The mention of cryonics interest suggests broader public and commercial awareness of long-term biological preservation, even outside core clinical uses. - Regional growth is likely to track healthcare infrastructure buildout and advanced research capacity, not just current market size.

What's next: - More investment is likely in cryogenic logistics, cold chain storage and high-purity medical gas production. - Healthcare providers and labs will need to meet stricter traceability and compliance expectations as usage expands. - The fastest growth is expected to come from Asia-Pacific as medical infrastructure and advanced therapies scale. - The report says demand should continue rising through 2030 as regenerative medicine and cell-based therapies expand.